271980 — Jeil Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
KR₩239bn
Enterprise Value
KR₩287bn
Revenue
KR₩726bn

Annual balance sheet for Jeil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13,520	6,588	28,003	31,589	35,658
Net Total Accounts Receivable
Net Total Receivables	161,883	156,922	146,689	153,267	166,225
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	264,134	277,513	284,672	291,641	317,046
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	120,438	115,547	125,710	138,402	137,041
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	400,396	409,663	426,486	456,892	487,326
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	208,519	218,058	221,943	268,657	318,170
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	231,541	237,269	258,273	298,983	328,756
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	168,855	172,394	168,213	157,909	158,570
Total Liabilities & Shareholders' Equity	400,396	409,663	426,486	456,892	487,326
Total Common Shares Outstanding